| Bone fractures and treatments | Lifetime | 110 | CN 3 | 99.20 |
| Pelvic and Acetabular Injuries | Lifetime | 104 | CN 2 | 99.18 |
| Hip and Femur Fractures | Lifetime | 116 | CN 1 | 99.22 |
| MicroRNA in disease regulation | Lifetime | 447 | CN 159 | 98.49 |
| Circular RNAs in diseases | Lifetime | 426 | CN 227 | 97.37 |
| Bone Metabolism and Diseases | Lifetime | 281 | CN 10 | 98.04 |
| Bone health and treatments | Lifetime | 447 | CN 8 | 97.90 |
| Mesenchymal stem cell research | Lifetime | 533 | CN 67 | 97.54 |
| Orthopedic Surgery and Rehabilitation | Lifetime | 739 | CN 9 | 97.74 |
| Orthopaedic implants and arthroplasty | Lifetime | 820 | CN 31 | 97.76 |
| Spine and Intervertebral Disc Pathology | Lifetime | 901 | CN 40 | 97.62 |
| Foot and Ankle Surgery | Lifetime | 421 | CN 10 | 96.17 |
| Orthopedic Infections and Treatments | Lifetime | 966 | CN 19 | 96.01 |
| Tendon Structure and Treatment | Lifetime | 656 | CN 30 | 95.85 |
| Osteoarthritis Treatment and Mechanisms | Lifetime | 973 | CN 69 | 96.15 |
| Shoulder and Clavicle Injuries | Lifetime | 846 | CN 6 | 95.11 |
| NF-κB Signaling Pathways | Lifetime | 846 | CN 55 | 93.35 |
| Scoliosis diagnosis and treatment | Lifetime | 949 | CN 91 | 92.03 |
| Surgical site infection prevention | Lifetime | 779 | CN 8 | 90.07 |
| Hydrogen's biological and therapeutic effects | Lifetime | 930 | CN 286 | 70.46 |
| Bone fractures and treatments | 2021-2025 | 4 | CN 1 | 99.62 |
| Hip and Femur Fractures | 2021-2025 | 14 | CN 2 | 99.27 |
| Pelvic and Acetabular Injuries | 2021-2025 | 20 | CN 5 | 98.39 |
| Orthopaedic implants and arthroplasty | 2021-2025 | 147 | CN 8 | 97.60 |
| Mesenchymal stem cell research | 2021-2025 | 91 | CN 35 | 95.87 |
| Bone Tissue Engineering Materials | 2021-2025 | 204 | CN 91 | 96.95 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 432 | CN 24 | 95.42 |
| MicroRNA in disease regulation | 2021-2025 | 787 | CN 480 | 92.38 |
| Osteoarthritis Treatment and Mechanisms | 2021-2025 | 383 | CN 125 | 92.53 |
| Bone Metabolism and Diseases | 2021-2025 | 189 | CN 83 | 88.09 |
| Spine and Intervertebral Disc Pathology | 2021-2025 | 906 | CN 194 | 91.89 |
| Adipose Tissue and Metabolism | 2021-2025 | 863 | CN 186 | 87.78 |
| Knee injuries and reconstruction techniques | 2021-2025 | 526 | CN 28 | 91.97 |
| Orthopedic Surgery and Rehabilitation | 2021-2025 | 786 | CN 22 | 89.32 |
| Vascular Procedures and Complications | 2021-2025 | 367 | CN 6 | 88.81 |
| Tendon Structure and Treatment | 2021-2025 | 486 | CN 78 | 86.93 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 311 | CN 37 | 84.35 |
| Orthopedic Infections and Treatments | 2021-2025 | 879 | CN 70 | 87.08 |
| Bone health and osteoporosis research | 2021-2025 | 581 | CN 63 | 84.27 |
| Surgical site infection prevention | 2021-2025 | 343 | CN 17 | 77.97 |
| Foot and Ankle Surgery | 2021-2025 | 622 | CN 70 | 84.09 |
| Periodontal Regeneration and Treatments | 2021-2025 | 791 | CN 109 | 80.75 |
| Elbow and Forearm Trauma Treatment | 2021-2025 | 553 | CN 22 | 78.28 |
| Hip disorders and treatments | 2021-2025 | 830 | CN 60 | 79.32 |
| Medical Malpractice and Liability Issues | 2021-2025 | 340 | CN 5 | 75.36 |
| Cardiac Ischemia and Reperfusion | 2021-2025 | 384 | CN 122 | 74.94 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 915 | CN 58 | 75.37 |
| Nosocomial Infections in ICU | 2021-2025 | 738 | CN 33 | 71.56 |
| Bone health and treatments | 2021-2025 | 935 | CN 157 | 71.82 |
| Pregnancy-related medical research | 2021-2025 | 677 | CN 60 | 70.60 |
| Vascular Malformations and Hemangiomas | 2021-2025 | 500 | CN 96 | 66.95 |
| Tumors and Oncological Cases | 2021-2025 | 701 | CN 60 | 66.36 |
| Lipid metabolism and disorders | 2021-2025 | 768 | CN 221 | 63.69 |
| Head and Neck Anomalies | 2021-2025 | 458 | CN 131 | 62.83 |
| Hippo pathway signaling and YAP/TAZ | 2021-2025 | 737 | CN 305 | 59.44 |
| Vascular anomalies and interventions | 2021-2025 | 983 | CN 104 | 48.32 |
